BlackRock Health Sciences Opps K (SHSKX)

Fund Assets	6.26B
Expense Ratio	0.741%
Min. Investment	$5,000,000
Turnover	49.00%
Dividend (ttm)	0.33
Dividend Yield	0.45%
Dividend Growth	10.98%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Jul 22, 2026

Previous Close	71.41
YTD Return	10.99%
1-Year Return	21.00%
5-Year Return	40.52%
52-Week Low	65.54
52-Week High	76.25
Beta (5Y)	0.69
Holdings	142
Inception Date	Jan 1, 2000

About SHSKX

The fund's core objective is to generate significant capital appreciation over the long term. It allocates a minimum of 80% of its total portfolio to equity investments, primarily common stocks, of companies engaged in the health sciences and related fields. This broad health sciences sector includes enterprises involved in healthcare equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals. Demonstrating a focused strategy, the fund will maintain a concentrated position, investing over 25% of its assets, in these health sciences or associated industries. Additionally, it possesses the flexibility to hold shares in companies located outside the United States.

• Fund Family: BlackRock
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Low
• Stock Exchange: Nasdaq
• Ticker Symbol: SHSKX
• Index: Russell 3000 Healthcare TR

Performance

SHSKX had a total return of 21.00% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.85%.

Top 10 Holdings

53.34% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	11.92%
Johnson & Johnson	JNJ	8.03%
Merck & Co., Inc.	MRK	5.56%
AbbVie Inc.	ABBV	5.07%
Thermo Fisher Scientific Inc.	TMO	4.41%
UnitedHealth Group Incorporated	UNH	4.33%
Gilead Sciences, Inc.	GILD	4.09%
Amgen Inc.	AMGN	3.98%
Vertex Pharmaceuticals Incorporated	VRTX	3.33%
Abbott Laboratories	ABT	2.61%

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 22, 2026	$6.46449	Jul 23, 2026
Dec 9, 2025	$3.1808	Dec 10, 2025
Jul 17, 2025	$3.83665	Jul 18, 2025
Dec 11, 2024	$3.38503	Dec 12, 2024
Jul 18, 2024	$2.49135	Jul 19, 2024
Dec 7, 2023	$1.39964	Dec 8, 2023

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 15, 2026

Data Sources Report a data error